Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist

Details for Australian Patent Application No. 2002360824 (hide)

Owner Merck & Co., Inc.

Inventors Liversidge, Elaine; Shel, Suhas D; Bosch, William H; Thompson, Karen C

Agent Spruson & Ferguson

Pub. Number AU-B-2002360824

PCT Number PCT/US02/41655

PCT Pub. Number WO2003/049718

Priority 60/340,040 10.12.01 US

Filing date 9 December 2002

Wipo publication date 23 June 2003

Acceptance publication date 8 May 2008

International Classifications

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/5377 (2006.01)

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/340,040 10.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002360824

8 May 2008 Application Accepted

  Published as AU-B-2002360824

22 May 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Merck & Co., Inc., Application No. 2002360824. under the INID (72), correct the name of the coinventor to Shelukar, Suhas D.

4 September 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp. 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002360825-DIFFUSION BARRIER LAYER IN SEMICONDUCTOR SUBSTRATES TO REDUCE COPPER CONTAMINATION FROM THE BACK SIDE

2002360823-TRANSFER MEMBER WITH ELECTRIC CONDUCTIVITY AND ITS MANUFACTURING METHOD